-
Document de presse | 2016.06.23
Antibodies that are effective against both dengue and Zika viruses
Scientists from the Institut Pasteur and the CNRS[1], in collaboration with Imperial College London and the University of Vienna, Austria, have identified antibodies that can efficiently neutralize both the dengue virus and the Zika virus. The description of the binding site for these antibodies on the viral envelope, identical for both viruses, could lead to the development of a universal...
-
Document de presse | 2010.01.17
Accor and the Institut Pasteur commit to preventing emerging diseases
The Institut Pasteur and Accor announce the implementation of an innovative partnership for health information and prevention aimed at travellers. "As guests of the Earth, we welcome the world” Since 2006, the social commitment of the 4000 hotels and 150,000 Accor employees has revolved around the "Earth Guest" programme, based on eight action centres, one of which being the...
-
Document de presse | 2005.01.10
SouthEast Asia: Institut Pasteur Mobilizes
In response to the risk of epidemics in the regions affected by the disaster, the Institut Pasteur, which is engaged in the battle against infectious diseases on a daily basis, has mobilized. The expert in charge of the Institut Pasteur Emergency Cell for Biological intervention (CIBU) is currently on a mission in Sri Lanka to participate in evaluating the risk of epidemics in this region. At the...
-
Document de presse | 2018.02.08
Anne Dejean-Assémat receives the Sjöberg Prize 2018
Professor Anne Dejean-Assémat, Head of the Nuclear Organization and Oncogenesis Unit at the Institut Pasteur and Inserm, has recently been awarded the Sjöberg Prize 2018, along with Professors Hugues de Thé from the Collège de France and Zhu Chen from Shanghai Jiao Tong University, China. This prize, awarded by the Royal Swedish Academy of Sciences, was set up in 2016 to recognize scientists...
-
News | 2020.02.06
Rabies: new prophylactic and therapeutic avenues
Rabies is still responsible for approximately 60,000 human deaths per year mostly in Asia and Africa and affects especially underserved people. Yet, since the first vaccine developed by Louis Pasteur more than 130 years ago, prophylactic measures have significantly improved. They are now composed of the vaccine allied to purified human or equine rabies immunoglobulins. However, these...
-
News | 2021.07.19
AFROSCREEN, boosting variant surveillance in 13 African countries
The Agence française de développement (AFD) and ANRS | Maladies infectieuses émergentes, in partnership with the Institut Pasteur, IRD, and laboratories across 13 African countries, are launching the joint AFROSCREEN project. This project meets an urgent need for surveillance of the development of SARS-CoV-2 variants and other emerging pathogens by bolstering laboratory genomic sequencing...
-
Document de presse | 2020.12.28
COVID-19: optimizing surveillance in long-term care facilities
Throughout the world, long-term care facilities have been high-risk sites for virus spread since the emergence of the COVID-19 epidemic. In this context, the capacity for timely surveillance and control of case numbers is essential in such facilities. Scientists at the Institut Pasteur have joined forces with the University of Versailles-Saint-Quentin-en-Yvelines, Inserm, and the National...
-
Document de presse | 2014.11.26
Ebola: a new Institut Pasteur is soon to be created in Guinea
Pr Christian Bréchot, President of the Institut Pasteur, will be in Guinea Friday 28th November 2014, alongside François Hollande, President of the French Republic. Two agreements will be signed, one with the government of Guinea and the other one with the French Agency for Development (AFD), allowing for the creation of a new Pasteur Institute in Conakry in late 2016. On Saturday 29th, Pr....
-
Document de presse | 2011.01.19
3D structure leads to first decoding of mechanism of action of general anesthetics
Two teams from the Institut Pasteur in association with the French National Center for Scientific Research (CNRS) have published in the journal Nature the three-dimensional structure of two general anesthetics bound to their membrane receptor. This research provides the first atomic-resolution structures of general anesthetics which can be used to understand their action mechanism, a mechanism...
-
Article | 2017.03.16
Workshop on Surveillance and Control of Rabies
The purpose of this course is to provide a practical training on rabies with a special focus on Middle East and Central Asia for students and professionals of animal and human public health sectors.